Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
| Condition | Heart Failure, Mitral Regurgitation |
|---|---|
| Phase | N/A |
| Sponsor | samir kapadia |
| Status | Active, not recruiting |
| Enrollment | 16 participants |
| Interventions | V-Wave Shunt Placement |
| Start date | Mar 11, 2021 |
| Completion date | Jan 3, 2025 |
| Results posted | Aug 5, 2026 |
Summary
This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
Number of Occurrence for Device-related Major Adverse Cardiovascular and Neurologic Events (MACNE)
| Treatment | 3 events |
|---|
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant — University of Utah
- Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure — Yale University
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using th — Boston Children's Hospital
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Endotronix, Inc.
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Crome/Cobalt Respiration Study — Medtronic Cardiac Rhythm and Heart Failure